Hepatic Angiomyolipoma: Contrast Patterns with SonoVue-enhanced Real-time Gray-scale Ultrasonography

  • Wei, Rui-Xue (Department of Ultrasound, Zhongshan Hospital, Fudan University) ;
  • Wang, Wen-Ping (Department of Ultrasound, Zhongshan Hospital, Fudan University) ;
  • Ding, Hong (Department of Ultrasound, Zhongshan Hospital, Fudan University) ;
  • Huang, Bei-Jian (Department of Ultrasound, Zhongshan Hospital, Fudan University) ;
  • Li, Chao-Lun (Department of Ultrasound, Zhongshan Hospital, Fudan University) ;
  • Fan, Pei-Li (Department of Ultrasound, Zhongshan Hospital, Fudan University) ;
  • Hou, Jun (Department of Pathology, Zhongshan Hospital, Fudan University) ;
  • He, Nian-An (Department of Ultrasound, Anhui provincial hospital of Anhui Medical University)
  • Published : 2012.02.29


This study was conducted to retrospectively evaluate the pattern of contrast enhancement with SonoVue on gray-scale ultrasonography of hepatic angiomyolipoma (HAML). Imaging features of 33 pathologically proven HAML lesions in 33 patients who underwent baseline ultrasound and contrast-enhanced ultrasonography (CEUS) were assessed retrospectively. All lesions were enhanced in the arterial phase and showed whole-tumor filling in. Thirty-two of 33 (97%) lesions showed early positive enhancement in the arterial phase. Twenty-three of these exhibited isoechoic or hyperechoic features in the portal phase. HAML demonstrate characteristic manifestations with SonoVue-enhanced real-time gray-scale ultrasonography.


Contrast agent;hepatic angiomyolipoma;microbubble;ultrasonography


  1. Burns PN, Wilson SR (2007). Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images. Radiology, 242, 162-74.
  2. Choi BI, Kim TK, Han JK, et al (2000). Vascularity of hepatocellular carcinoma: assessment with contrastenhanced second-harmonic versus conventional power Doppler US. Radiology 214, 381-6.
  3. Ding H, Wang WP, Huang BJ, et al (2005). Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med, 24, 285-97
  4. Fan ZH, Chen MH, Dai Y, et al (2006). Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. AJR Am J Roentgenol, 186, 1512-9.
  5. Isozaki T, Numata K, Kiba T, et al (2003). Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology, 229, 798-805.
  6. Jang HJ, Kim TK, Burns PN, Wilson SR (2007). Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology, 244, 898-906
  7. Kim JH, Kim TK, Kim BS, et al (2002). Enhancement of hepatic hemangiomas with levovist on coded harmonic angiographic ultrasonography. J Ultrasound Med, 21, 141-8.
  8. Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR (2008). Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrastenhanced sonography. AJR Am J Roentgenol, 190, 58-66.
  9. Leslie DF, Johnson CD, Johnson CM, Ilstrup DM, Harmsen WS (1995). Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns. AJR Am J Roentgenol, 164, 625-9.
  10. Li R, Zhang X, Hua X, et al (2010). Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas. Abdom Imaging, 35, 676-82.
  11. Ogawa S, Kumada T, Toyoda H, et al (2006). Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen. Eur J Radiol, 59, 74-81.
  12. Takahara M, Miyake Y, Matsumoto K, et al (2009). A case of hepatic angiomyolipoma difficult to distinguish from hepatocellular carcinoma. World J Gastroenterol, 15, 2930-2.
  13. Tsui WM, Colombari R, Portmann BC, et al (1999). Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol, 23, 34-48.
  14. Trillaud H, Bruel JM, Valette PJ, et al (2009). Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol, 15, 3748-56.
  15. Uggowitzer M, Kugler C, Groll R, et al (1998). Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist). Br J Radiol, 71, 1026-32.
  16. Von Herbay A, Westendorff J, Gregor M (2010). Contrastenhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients. J Clin Ultrasound, 38, 1-9.
  17. Wang Z, Xu HX, Xie XY, et al (2010). Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound. Br J Radiol, 83, 411-8.
  18. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X (2010). Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology, 215, 153-61.
  19. Yan F, Zeng M, Zhou K, et al (2002). Hepaticangiomyolipoma: various appearances on two-phase contrast scanning of spiral CT. Eur J Radiol, 41, 12-8.
  20. Yen YH, Wang JH, Lu SN, Changchien CS (2005). Contrastenhanced ultrasonography in hepatic angiomyolipoma. J Ultrasound Med, 24, 855-9.

Cited by

  1. Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound—A Prospective Study in Non-Cirrhotic Patients vol.10, pp.7, 2015,